133 related articles for article (PubMed ID: 30689515)
1. Genetically detoxified pertussis toxin induces superior antigen specific CD4 T cell responses compared to chemically detoxified pertussis toxin.
Surendran N; Pichichero M
Hum Vaccin Immunother; 2019; 15(5):1167-1170. PubMed ID: 30689515
[TBL] [Abstract][Full Text] [Related]
2. Genetically detoxified pertussis toxin (PT-9K/129G): implications for immunization and vaccines.
Seubert A; D'Oro U; Scarselli M; Pizza M
Expert Rev Vaccines; 2014 Oct; 13(10):1191-204. PubMed ID: 25183193
[TBL] [Abstract][Full Text] [Related]
3. Neonatal immunization with a single dose of recombinant BCG expressing subunit S1 from pertussis toxin induces complete protection against Bordetella pertussis intracerebral challenge.
Nascimento IP; Dias WO; Quintilio W; Christ AP; Moraes JF; Vancetto MD; Ribeiro-Dos-Santos G; Raw I; Leite LC
Microbes Infect; 2008 Feb; 10(2):198-202. PubMed ID: 18248757
[TBL] [Abstract][Full Text] [Related]
4. A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults.
Leroux-Roels G; Lattanzi M; Solis CD; Contorni M; Costantini M; Moraschini L; Bardelli M; Bertholet S; Borgogni E; Buricchi F; Cantisani R; Faenzi E; Finco O; Leuzzi R; Pizza M; Rosa D; Schiavetti F; Seubert A; Spensieri F; Volpini G; Zedda L; Giudice GD; Galgani I
Hum Vaccin Immunother; 2018 Jan; 14(1):45-58. PubMed ID: 29172945
[TBL] [Abstract][Full Text] [Related]
5. Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial.
Blanchard Rohner G; Chatzis O; Chinwangso P; Rohr M; Grillet S; Salomon C; Lemaître B; Boonrak P; Lawpoolsri S; Clutterbuck E; Poredi IK; Wijagkanalan W; Spiegel J; Pham HT; Viviani S; Siegrist CA
Clin Infect Dis; 2019 Mar; 68(7):1213-1222. PubMed ID: 30759183
[TBL] [Abstract][Full Text] [Related]
6. An international collaborative study of the effect of active pertussis toxin on the modified Kendrick test for acellular pertussis vaccines.
Xing D; Gaines Das R; Douglas-Bardsley A; Asokanathan C; Corbel M
Biologicals; 2014 Mar; 42(2):101-8. PubMed ID: 24388289
[TBL] [Abstract][Full Text] [Related]
7. The vaccine containing recombinant pertussis toxin induces early and long-lasting protection.
Rappuoli R
Biologicals; 1999 Jun; 27(2):99-102. PubMed ID: 10600193
[TBL] [Abstract][Full Text] [Related]
8. Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a phase 2/3 randomised, controlled, non-inferiority trial.
Pitisuttithum P; Chokephaibulkit K; Sirivichayakul C; Sricharoenchai S; Dhitavat J; Pitisuthitham A; Phongsamart W; Boonnak K; Lapphra K; Sabmee Y; Wittawatmongkol O; Chauhan M; Wijagkanalan W; Hommalai G; Fortuna L; Chinwangso P; Poredi IK; van den Biggelaar AHJ; Pham HT; Viviani S
Lancet Infect Dis; 2018 Nov; 18(11):1260-1268. PubMed ID: 30266329
[TBL] [Abstract][Full Text] [Related]
9. Development and clinical testing of an acellular pertussis vaccine containing genetically detoxified pertussis toxin.
Rappuoli R; Pizza M; De Magistris MT; Podda A; Bugnoli M; Manetti R; Nencioni L
Immunobiology; 1992 Feb; 184(2-3):230-9. PubMed ID: 1587545
[TBL] [Abstract][Full Text] [Related]
10. Effect of different detoxification procedures on the residual pertussis toxin activities in vaccines.
Yuen CT; Asokanathan C; Cook S; Lin N; Xing D
Vaccine; 2016 Apr; 34(18):2129-34. PubMed ID: 26973066
[TBL] [Abstract][Full Text] [Related]
11. Acellular pertussis vaccines containing genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults.
Di Tommaso A; Bartalini M; Peppoloni S; Podda A; Rappuoli R; De Magistris MT
Vaccine; 1997 Aug; 15(11):1218-24. PubMed ID: 9286047
[TBL] [Abstract][Full Text] [Related]
12. Aluminum hydroxide adjuvant diverts the uptake and trafficking of genetically detoxified pertussis toxin to lysosomes in macrophages.
Jaldin-Fincati J; Moussaoui S; Gimenez MC; Ho CY; Lancaster CE; Botelho R; Ausar F; Brookes R; Terebiznik M
Mol Microbiol; 2022 May; 117(5):1173-1195. PubMed ID: 35344242
[TBL] [Abstract][Full Text] [Related]
13. Investigating pertussis toxin and its impact on vaccination.
Coutte L; Locht C
Future Microbiol; 2015; 10(2):241-54. PubMed ID: 25689536
[TBL] [Abstract][Full Text] [Related]
14. Genetically detoxified pertussis toxin induces Th1/Th17 immune response through MAPKs and IL-10-dependent mechanisms.
Nasso M; Fedele G; Spensieri F; Palazzo R; Costantino P; Rappuoli R; Ausiello CM
J Immunol; 2009 Aug; 183(3):1892-9. PubMed ID: 19596995
[TBL] [Abstract][Full Text] [Related]
15. DNA vaccine encoding pertussis toxin S1 subunit induces protection against Bordetella pertussis in mice.
Kamachi K; Konda T; Arakawa Y
Vaccine; 2003 Nov; 21(31):4609-15. PubMed ID: 14575775
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated immune response of healthy adults to Bordetella pertussis vaccine antigens.
Ausiello CM; Lande R; la Sala A; Urbani F; Cassone A
J Infect Dis; 1998 Aug; 178(2):466-70. PubMed ID: 9697728
[TBL] [Abstract][Full Text] [Related]
17. In vitro induction of antigen specific antibody synthesis and proliferation of T lymphocytes with acellular pertussis vaccines, pertussis toxin and filamentous haemagglutinin in humans.
Wiertz EJ; Loggen HG; Walvoort HC; Kreeftenberg JG
J Biol Stand; 1989 Apr; 17(2):181-90. PubMed ID: 2785517
[TBL] [Abstract][Full Text] [Related]
18. Acellular pertussis vaccine composed of genetically inactivated pertussis toxin.
Peppoloni S; Pizza M; De Magistris MT; Bartoloni A; Rappuoli R
Physiol Chem Phys Med NMR; 1995; 27(4):355-61. PubMed ID: 8768791
[TBL] [Abstract][Full Text] [Related]
19. Genetically detoxified pertussis toxin displays near identical structure to its wild-type and exhibits robust immunogenicity.
Ausar SF; Zhu S; Duprez J; Cohen M; Bertrand T; Steier V; Wilson DJ; Li S; Sheung A; Brookes RH; Pedyczak A; Rak A; Andrew James D
Commun Biol; 2020 Aug; 3(1):427. PubMed ID: 32759959
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the carbohydrate binding and ADP-ribosyltransferase activities of chemically detoxified pertussis toxins.
Oh H; Kim BG; Nam KT; Hong SH; Ahn DH; Choi GS; Kim H; Hong JT; Ahn BY
Vaccine; 2013 Jun; 31(29):2988-93. PubMed ID: 23664992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
